Anita Wagner

Anita Katharina Wagner, PharmD, MPH, DrPH

Fellow in Bioethics

Anita Katharina Wagner is Associate Professor in the Division of Health Policy and Insurance Research at the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She also serves as the Director of the Harvard Pilgrim Health Care Ethics Program

Dr. Wagner conducts empirical research generating evidence for answering challenging health system questions.  Her work, frequently in large databases, evaluates impacts of insurance and other policy changes on the availability, access to, affordability, and use of medicines, specifically new cancer medicines, in the United States, China, and elsewhere.    

Through the Medicines and Insurance Coverage (MedIC) Initiative she founded, Dr. Wagner has led training programs, including the first online course, to strengthen capacity of professionals in more than 20 low and middle income country health systems to design, implement, monitor and evaluate medicines policies and programs in the context of expanding health insurance coverage.

Dr. Wagner co-directs the Harvard Medical School Fellowship in Health Policy and Insurance Research and the Department of Population Medicine Center for Cancer Policy and Program Evaluation (CarPE)

Serving as a pharmacoepidemiologist on the FDA’s Sentinel Initiative, Dr. Wagner contributes to a national system that tracks the safety of pharmaceuticals in the United States. 

Dr. Wagner holds a German master-equivalent degree in pharmacy, a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences, a Master of Public Health degree in international health and a Doctor of Public Health degree in epidemiology from the Harvard School of Public Health. She completed training programs in bioethics including the Harvard Medical School Fellowship in Bioethics.

Publications View
Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.
Authors: Authors: Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF.
Breast Cancer Res Treat
View full abstract on Pubmed
Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.
Authors: Authors: Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF.
Breast Cancer Res Treat
View full abstract on Pubmed
Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.
Authors: Authors: Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, Chaiyakunapruk N.
BMJ Open
View full abstract on Pubmed
Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change?
Authors: Authors: Leopold C, Chambers JD, Wagner AK.
Value Health
View full abstract on Pubmed
Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
Authors: Authors: Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan D.
Health Policy Plan
View full abstract on Pubmed
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
Authors: Authors: Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CY.
Clin Ther
View full abstract on Pubmed
Policies and programs to facilitate access to targeted cancer therapies in Thailand.
Authors: Authors: Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK.
PLoS One
View full abstract on Pubmed
Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.
Authors: Authors: Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK.
J Pharm Policy Pract
View full abstract on Pubmed
Patient access schemes in Asia-pacific markets: current experience and future potential.
Authors: Authors: Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AK.
J Pharm Policy Pract
View full abstract on Pubmed
Quality use of medicines within universal health coverage: challenges and opportunities.
Authors: Authors: Wagner AK, Quick JD, Ross-Degnan D.
BMC Health Serv Res
View full abstract on Pubmed

Address: 
Harvard Pilgrim Health Care Institute
Landmark Center
401 Park Dr
Boston, MA 02215